Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions

US11278503B2 · kind B2 · utility

Assignee

• NOVALIQ GMBH · DE

Inventors

• Bernhard Günther · Dossenheim, DE
• Markus Beier · Heidelberg, DE
• Oliver Felix-Karl Schlüter · Leverkusen, DE

Key dates

• Filing date: May 9, 2018
• Grant date: Mar 22, 2022
• Expiry date: Oct 31, 2038

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P27/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A pharmaceutical composition comprising a semifluorinated alkane of formula (I): F(CF2)n(CH2)mH, wherein n is an integer from 4 to 6, and m is an integer from 5 to 8, for use in the treatment or prevention of a disease or condition relating to an ocular surface of an eye of an individual, wherein the individual is a contact lens wearer, and wherein the contact lens is a hydro gel contact lens and the composition is administered topically to a surface of the eye of the individual before the contact lens is inserted to the eye of the individual and/or during contact lens wear and/or after the contact lens has been removed from the eye of the individual, or wherein the contact lens is a silicone hydrogel contact lens and the composition is administered topically to a surface of the eye of the individual after the contact lens has been removed from the eye of the individual.